Articles tagged with Attention Deficit Hyperactivity Disorder
A Swedish study found strong links between ADHD medication and limited maternal education, single parent families, and welfare benefits among 1.16 million school children. The study showed that socioeconomic factors accounted for almost half of the cases, highlighting their potent predictive power.
A recent study published in Pediatrics found a connection between exposure to organophosphate pesticides and symptoms of Attention-Deficit Hyperactivity Disorder (ADHD) in children. The research, which focused on 1,139 children from the general U.S. population, measured pesticide levels in their urine and found that exposure to common ...
A new study by Michigan State University researchers highlights the need for culturally competent health-care providers and information dissemination about treatment options. The study found that minorities are less likely to consider combining medication and counseling for their children due to barriers such as financial hurdles and l...
Children with a specific dopamine receptor gene variant respond better to methylphenidate, a commonly used ADHD medication, according to a new study. The findings aim to improve treatment outcomes and reduce healthcare costs by tailoring approaches to each child based on their genetic profile.
Researchers found that behavioral incentives and medication have similar effects on brain function in children with ADHD, improving attention and reducing impulsivity. The study suggests that combining both approaches may be the most effective way to treat the condition.
A study found that children with ADHD exhibit more symptoms when they experience high levels of self-blame during inter-parental conflict, which is associated with genetic variations related to serotonin activity. The study suggests a synergistic effect between genetic and environmental factors in the development of ADHD.
A study published in Biological Psychiatry compared the effects of medication, motivation, and a combination of both on response inhibition in children with ADHD. The results showed that stimulant medication tends to normalize brain function, while motivational incentives also play a role in improving performance.
Researchers found that behavioral incentives improved attention and reduced impulsivity in children with ADHD, normalizing brain activity similar to that of control groups. Medication had the most significant effect, but combining it with rewards and incentives boosted its benefits.
Researchers at Mount Sinai Hospital found that meta-cognitive therapy significantly improved symptoms of attention deficit hyperactivity disorder (ADHD) in adults compared to supportive therapy. The study, published in the American Journal of Psychiatry, demonstrated the efficacy of a non-medication treatment for adult ADHD.
Neuroscientist David Anderson explains how studying model organisms like mice and fruit flies can improve understanding of the neural basis of emotion. He also discusses the limitations of human brain studies and the potential of new technologies to experimentally manipulate brain circuitry.
Children with ADHD exhibit reduced ventral striatum volumes associated with symptoms of hyperactivity and impulsiveness. The study suggests that motivational deficiencies contribute to ADHD's imbalance in attention and hyperactivity levels.
Recent studies found a link between low-level lead exposure and ADHD symptoms, including hyperactivity and impulsivity. Lead is thought to disrupt brain activity, causing altered psychological processes supported by these neurons.
Researchers found distinct neurophysiological patterns in ADHD symptoms between children with and without prenatal alcohol exposure, suggesting different underlying processes. The study's findings may provide new insights into the effects of prenatal alcohol exposure on ADHD treatment.
A new study published in Pediatrics found that mixed-handed children are twice as likely to have difficulties with language and perform poorly in school compared to their right-handed peers. They also showed higher risk of attention deficit/hyperactivity disorder (ADHD) symptoms, especially at adolescence.
Children with ADHD show a disconnection between brain regions responsible for attention and visual processing, leading to inefficient resource allocation. This discovery provides new insights into the condition and highlights the need for behavioral definitions to be reevaluated.
A nationally representative survey found that about 13% of American children and teenagers have a mental disorder, with lower socioeconomic status linked to higher rates. Mental health services are often underutilized, particularly among minority youth, highlighting the need for increased access and support.
The First Step To Success program has shown robust improvements among at-risk elementary students in the Albuquerque, N.M., school district. The four-year study found significant impact on behavioral symptoms and social functioning among participating students, with effect sizes ranging from .54 to .87.
Children exposed prenatally to tobacco smoke and during childhood to lead face a high risk for Attention Deficit Hyperactivity Disorder (ADHD). The study estimates that up to 35% of ADHD cases could be reduced by eliminating these environmental exposures.
A study published in Biological Psychiatry found a significant positive association between phthalate exposure and ADHD symptoms in school-aged children. The researchers measured urine phthalate concentrations and evaluated symptoms of attention-deficit/hyperactivity disorder (ADHD) using teacher-reported symptoms and computerized tests.
INTUNIV, a selective alpha-2A agonist, shows no unique adverse effects when coadministered with amphetamine or methylphenidate. The study demonstrated improved ADHD symptoms using the ADHD Rating Scale-IV (ADHD-RS-IV) in children and adolescents.
A post hoc analysis of Phase 3 study data found that Vyvanse significantly improved emotional lability composite CPRS-RS scores in children with ADHD aged 6 to 12 years. Treatment with Vyvanse yielded significant improvements in emotional lability scores only for those with prominent emotional lability prior to treatment.
A Phase IIIb study of Daytrana found significant improvements in ADHD symptoms in adolescents aged 13-17 years, with most adverse events mild to moderate. Pharmacokinetic data also showed similar exposure to d-MPH in both children and adolescents.
Shire presents new scientific data on its ADHD portfolio, including INTUNIV, Vyvanse, and Daytrana. The company's ADHD business unit is committed to advancing treatment research and developing safe and effective treatments.
INTUNIV demonstrated significant efficacy in reducing symptoms of attention deficit hyperactivity disorder (ADHD), particularly oppositional symptoms, in children and adolescents. The study showed improved symptoms as measured by the Conners' Parent Rating Scale-Revised: Long Form (CPRS-R:L) and ADHD Rating Scale-IV (ADHD-RS-IV).
The Canadian Cardiovascular Society has released new guidelines for the management of adults with congenital heart disease, cardiovascular risk evaluation tools, and simplified target levels. The guidelines aim to provide evidence-based medicine for clinicians and improve heart health in Canadians.
A study by IMpACT, an international collaboration of researchers, suggests that adult ADHD has a high genetic component. The findings indicate that multiple gene defects contribute to the disorder, with heritability estimates ranging from 60%. This research aims to identify risk genes for ADHD and develop effective treatments.
A brain-imaging study found that ADHD patients have lower-than-normal dopamine markers, which may underlie symptoms of inattention and reduced motivation. This deficit could lead to complications like drug abuse and obesity.
A study found that Vyvanse significantly reduced ADHD symptoms in children aged 6-12 from 1.5 to 13 hours after taking the medication. The study, published online in Child and Adolescent Psychiatry and Mental Health, demonstrated long-lasting efficacy of Vyvanse in improving behavior and attention.
A study comparing children with FASD and ADHD reveals significant differences in social cognition and emotional processing. Children with FASD show a distinct profile of weaker social skills, including high distractibility and restlessness, which may underlie the severe conduct problems observed in these individuals.
Researchers at Queen's University have created eye movement tests to aid in understanding childhood brain development, healthy aging, and the diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) and Parkinson's disease. The study found that children scored low on these tests, while those with ADHD showed decreased normal brain ...
In a simulated workplace environment study, VYVANSE CII improved ADHD symptoms of inattention, hyperactivity, and impulsivity, as measured by the Permanent Product Measure of Performance (PERMP) and ADHD Rating Scale (ADHD-RS). Adults taking VYVANSE showed significant efficacy at 14 hours after administration.
Pediatric researchers found hundreds of gene variations associated with ADHD, many linked to learning, behavior, and brain function. The study suggests future drug targets and personalized treatments may be possible.
Coadministration of Prilosec OTC 40 mg did not alter maximum plasma concentration or area under curve for active medication in both VYVANSE and ADDERALL XR. The study also found a significant reduction in time to reach maximum plasma concentrations of amphetamine with coadministration of Prilosec OTC 40 mg.
INTUNIV demonstrated significant efficacy in treating ADHD symptoms, particularly in children aged 6-12 years with oppositional behaviors. The study showed improved symptom reduction on various rating scales, including the ADHD Rating Scale-IV and Clinical Global Impressions-Improvement.
Shire plc will present key scientific data on its Attention Deficit Hyperactivity Disorder (ADHD) treatments lisdexamfetamine dimesylate and investigational non-scheduled guanfacine extended release. The presentations include studies on the pharmacokinetics, duration of effects, patient experience, and response to treatment.
Children with high blood pressure are more likely to have learning disabilities and ADHD, with a four-fold increased risk. The study also found that hypertensive children have difficulties in goal-directed tasks and working memory.
A study reveals that adolescents with ADHD are more likely to experience current and lifetime sleep problems and disorders, regardless of ADHD symptom severity. Mental health professionals are advised to screen for sleep problems and psychiatric comorbidities in all adolescents with a childhood ADHD diagnosis.
A recent Finnish study found that short sleep duration increases risk for behavioral symptoms of ADHD, even without sleeping difficulties. The researchers tracked 280 healthy children and found a higher hyperactivity and impulsivity score with shorter sleep duration.
Research published in the Journal of Developmental and Behavioural Pediatrics found that nearly 90% of Tourette syndrome cases exist in conjunction with another disorder, most frequently ADHD. Perinatal factors such as low birth weight, prematurity, and maternal smoking increase the risk of co-occurring ADHD in children with Tourette.
Research shows in-clinic therapy and at-home reinforcement are more effective than home-based programs in treating convergence insufficiency, a condition that affects students' performance in school.
A study by UC Davis M.I.N.D. Institute found that children with ADHD exhibit variable response times during working memory tasks, even when accuracy is similar to typically developing peers. Higher levels of hyperactivity and impulsivity are associated with slower reaction times.
A distinct alpha-wave pattern occurs just before subjects make mistakes on attention-demanding tests, suggesting a potential method for monitoring attention and predicting errors. The discovery could lead to practical applications in air traffic control and new therapies for children with ADHD.
Researchers discovered an abnormality in the brains of adolescent boys with attention deficit hyperactivity disorder, particularly in the anterior cingulate cortex. This region normally activates when a reward stops, but in boys with ADHD, it fails to do so, leading to continued activation and impulsive behavior.
A new University of Central Florida study may explain why children with attention deficit hyperactivity disorder (ADHD) move around a lot. The research found that children with ADHD become significantly more active when required to remember and manipulate computer-generated letters, numbers, and shapes for a short time.
A new study reveals that children with attention deficit/hyperactivity disorder (ADHD) have a shorter total sleep time and reduced rapid eye movement (REM) sleep compared to healthy controls. This intrinsic sleep problem may contribute to the symptoms of ADHD.
Studies find that access to nature reduces aggression, crime rates, and improves cognitive function in children with ADHD. Living near trees also positively influences mood, life satisfaction, and social interactions, particularly among elderly adults.
Two studies examine over 600,000 genetic markers in ADHD patients, finding that multiple genes contribute to the disorder. The findings highlight the need for larger studies to fully understand the genetic mechanisms underlying ADHD and to develop more effective treatments.
A study found Transcendental Meditation (TM) significantly reduced ADHD symptoms, stress, and anxiety among middle school students. TM improved attention, working memory, organization, and behavior regulation, enabling teachers to teach more effectively.
A study of smokers with attention deficit and hyperactivity symptoms found those with elevated hyperactivity and impulsivity showed lower quit rates compared to those with inattention or no A.D.H.D. symptoms.
Researchers at NIH and Duke University Medical Center found no evidence of cytogenetic damage in children taking stimulant medications for ADHD. The study included 63 children aged 6-12 who received either methylphenidate or mixed amphetamine salts, and showed similar results with both treatments.
Researchers have uncovered structural features of the brain that may contribute to the development of ADHD. The study used a new analysis tool to examine shape differences in the brains of children with ADHD and found significant abnormalities in boys, but not girls.
Researchers from the Kennedy Krieger Institute found that girls with ADHD experience fewer motor skill difficulties compared to their male peers. The study suggests that sex-related differences in children with ADHD extend beyond symptom presentation, and that girls may outgrow ADHD-related motor skill deficits before age 7.
Research suggests that ADHD impacts movement control differently in boys and girls, with girls showing better coordination skills despite having the disorder. Girls with ADHD are twice as likely to perform movements typically expected for their age compared to boys with ADHD.
The study found that VYVANSE controlled ADHD symptoms from the first time point measured through the last time point assessed. In addition, VYVANSE treatment was associated with significant improvement in math problems attempted and answered correctly for up to 13 hours post-dose.
Young people with ADHD are more likely to become dependent on nicotine and experience environmental factors that increase their risk of smoking. The study found that individuals with more ADHD-related symptoms were at greater risk of nicotine dependence than those with fewer symptoms.
Parents of a child with ADHD nearly twice as likely to divorce by age 8 compared to parents without ADHD. Marriages involving children with ADHD ended sooner than those without ADHD.
Research conducted at the University of Illinois shows that children with ADHD demonstrate greater attention after a 20-minute walk in a park compared to similar walks in downtown or residential areas. The study found that even small doses of nature exposure can improve symptoms, suggesting a potential long-term benefit.
LIALDA demonstrated a steady 5-ASA release throughout the entire colon, with prolonged disintegration in the ascending colon. A post hoc analysis also found that patients could achieve complete symptom resolution after up to 16 weeks of LIALDA treatment.
Researchers found that treatment with stimulant drugs significantly decreased the risk that girls with ADHD will begin smoking cigarettes or using alcohol or drugs. The study's results mirror those of earlier studies in boys and suggest a potential protective effect of stimulant treatment.
Researchers found a genetic change in the dopamine transporter protein that makes it behave as if amphetamine is present, leading to altered dopamine signaling and contributing to ADHD symptoms. The altered function supports a role for dopamine signaling in the disease.